Hjem › Gliom › Ohio › Columbus
Kliniske studier for Gliom i Columbus, OH
15 studier for Gliom søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservasjonsstudie
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Rekrutterer
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RekruttererFase 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
RekruttererFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RekruttererTidlig fase 1
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
RekruttererFase 1
- Nationwide Children's Hospital, Columbus
Gliom-studier i andre byer
- New York City, NY25 studier
- Houston, TX23 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Miami, FL15 studier
- San Francisco, CA14 studier
- Chicago, IL13 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- Los Angeles, CA10 studier
- St. Louis, MO10 studier
Andre studier i Columbus
- Ikke-småcellet lungekreft56 studier
- Brystkreft39 studier
- Eggstokkreft39 studier
- Kreft (alle typer)38 studier
- Lungekreft37 studier
- Akut myelogen leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastatisk kreft27 studier
- Endometriekreft25 studier
- Kolorektal kreft24 studier
- Prostatakreft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.